A
DAWN

AlphaQuest’s Day One Biopharmaceuticals DAWN Stock Holding History

AlphaQuest’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,326
Closed -$329K – 542
2025
Q4 		$329K Sell
35,326
-149,680
-81% -$1.25M 0.02% 1141
2025
Q3 		$1.3M Buy
185,006
+169,134
+1,066% +$1.16M 0.09% 325
2025
Q2 		$103K Sell
15,872
-46,080
-74% -$317K 0.01% 1419
2025
Q1 		$491K Buy
61,952
+58,556
+1,724% +$631K 0.05% 527
2024
Q4 		$43K Sell
3,396
-4,355
-56% -$60.6K 0.01% 1319
2024
Q3 		$108K Buy
7,751
+7,668
+9,239% +$109K 0.01% 1263
2024
Q2 		$1.14K Sell
83
-9,133
-99% -$134K ﹤0.01% 1368
2024
Q1 		$152K Buy
9,216
+7,236
+365% +$108K 0.03% 732
2023
Q4 		$28.9K Buy
+1,980
New +$24K 0.01% 939

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

AlphaQuest's DAWN Position: Q1 2026 in Review

AlphaQuest sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 35,326 shares — an estimated $329K sold.

AlphaQuest first reported a position in DAWN in Q4 2023 and held it in 9 quarters. The position peaked at $1.3M in Q3 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • AlphaQuest reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 35,326 Day One Biopharmaceuticals shares in Q1 2026, an estimated $329K.
  • AlphaQuest first reported a position in Day One Biopharmaceuticals in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Day One Biopharmaceuticals position peaked at $1.3M in Q3 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.